Score Overview
Karyopharm Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 108M to $ 146M and net income went from -$ 196M to -$ 196M. Revenue increased in 2 of those 5 years; net income in 3.
Across Karyopharm Therapeutics Inc's full reported history, from 2013 to 2025, revenue grew from $ 387K to $ 146M and net income went from -$ 33M to -$ 196M. Revenue increased in 62% of the years measured; net income in 46%.
Karyopharm Therapeutics Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.03 | — |
1 Year2025-08-12 | $ 4.02 | -49.50% |
5 Years2021-08-12 | $ 72.30 | -97.19% |
10 Years2016-08-12 | $ 104.55 | -98.06% |
All Time2013-11-06 | $ 240.75 | -99.16% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2013-11-06 |
|---|---|---|---|---|---|
| Price | $ 2.03 | $ 4.02 | $ 72.30 | $ 104.55 | $ 240.75 |
| Return | — | -49.50% | -97.19% | -98.06% | -99.16% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 151M | -$ 194M | $ 90M |
| 2025 | $ 146M | -$ 196M | $ 63M |
| 2024 | $ 145M | -$ 76M | $ 108M |
| 2023 | $ 146M | -$ 143M | $ 191M |
| 2022 | $ 157M | -$ 165M | $ 277M |
| 2021 | $ 209M | -$ 124M | $ 228M |
| 2020 | $ 108M | -$ 196M | $ 273M |
| 2019 | $ 40M | -$ 199M | $ 263M |
| 2018 | $ 30M | -$ 178M | $ 328M |
| 2017 | $ 1M | -$ 128M | $ 146M |
| 2016 | $ 154K | -$ 109M | $ 129M |
| 2015 | $ 250K | -$ 118M | $ 175M |
| 2014 | $ 229K | -$ 75M | $ 205M |
| IPO2013 | $ 387K | -$ 33M | $ 155M |
Explore beyond KPTI
You're looking at Karyopharm Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
